Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertindole vs Olanzapine Metabolic Effects in Schizophrenia
NCT00759460Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Mar 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertindole in schizophrenia (2 arms), sponsored by Lundbeck. Primary endpoint: Changes from baseline in components of the metabolic syndrome at 12 weeks. Started Mar 2007; status: completed.
02
Drugs
sertindole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00759460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759460.